A Study of the Safety of REN001 in Patients With McArdle Disease

McArdle Disease Clinical Trial

Official title:
A Phase 1b, Open-label Study to Evaluate the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Patients With McArdle Disease (Glycogen Storage Disorder 5)

Status Completed

Clinical Trial Summary

The purpose of this study is to assess REN001 safety in subjects with McArdle Disease

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04226274
Study type	Interventional
Source	Reneo Pharma Ltd
Contact
Status	Completed
Phase	Phase 1
Start date	December 10, 2019
Completion date	October 11, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03945370` - Oral Ketone Body Supplementation in Patients With McArdle Disease	N/A
Completed	`NCT04349566` - Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
Enrolling by invitation	`NCT03211923` - Muscle Relaxation in Myopathies With Positive Muscle Phenomena
Completed	`NCT03112889` - Sodium Valproate for GSDV	Phase 2
Completed	`NCT04694547` - Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)
Completed	`NCT03843606` - Modified Ketogenic Diet in Patients With McArdle Disease Part A	N/A
Recruiting	`NCT04929002` - Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
Completed	`NCT04044508` - Modified Ketogenic Diet in Patients With McArdle Disease Part B	N/A
Recruiting	`NCT05943678` - Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.